首页> Clinical genetics> Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.

Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.

导出 LinkOut

翻译打印收藏纠错

第一作者： L M,Pelttari

第一单位： Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

作者： L M,Pelttari ^[1] ; H,Shimelis ^[2] ; H,Toiminen ^[3] ; A,Kvist ^[4] ; T,Törngren ^[4] ; Å,Borg ^[4] ; C,Blomqvist ^[5] ; R,Bützow ^[6] ; F,Couch ^[2] ; K,Aittomäki ^[3] ; H,Nevanlinna ^[1]

作者单位： Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. ^[1] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. ^[2] Department of Clinical Genetics, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland. ^[3] Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. ^[4] Department of Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. ^[5] Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.;Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. ^[6]

关键词 RAD51C breast cancer gene-panel ovarian cancer